In ccRCC, mutations in VHL result in the accumulation of HIF-2α, which creates a state of “pseudo-hypoxia” (28) and induces metabolic changes, including angiogenesis, epithelial-mesenchymal transition, invasion, and metastatic spread (29). Here, VHL is linked to nonpapillary renal cell carcinoma.